Final Recommendation Statement: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia
The U.S. Preventive Services Task Force released today a final recommendation statement on low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia. To view the recommendation and the evidence on which it is based, please go to http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication. A fact sheet that explains the final recommendation in plain language is also available. The final recommendation statement can also be found in the September 9 online issue of Annals of Internal Medicine.
Internet Citation: Final Recommendation Statement: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia. U.S. Preventive Services Task Force. September 2014.